Califf talks bol­ster­ing do­mes­tic drug man­u­fac­tur­ing, for­eign in­spec­tions at House hear­ing

FDA Com­mis­sion­er Robert Califf told law­mak­ers he’s ready to work with them to bring more drug man­u­fac­tur­ing to the US and laid out the agency’s progress to ramp up over­seas in­spec­tions at a con­gres­sion­al hear­ing Thurs­day.

Ap­pear­ing be­fore a House Ap­pro­pri­a­tions pan­el to de­fend the agency’s bud­get re­quest for fis­cal year 2025, rep­re­sen­ta­tives pep­pered Califf with ques­tions about how the FDA can play a role in reshoring over­seas gener­ic drug man­u­fac­tur­ing to the US. He al­so told the pan­el that while chal­leng­ing, the FDA has made some progress in con­duct­ing more unan­nounced in­spec­tions over­seas.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER